Individually tailored immunosuppression: Is there a role for biomarkers?

Clinical Chemistry

Volumn 57, Issue 3, 2011, Pages 376-381

  Brandhorst, Gunnar ^a   Oellerich, Michael ^a   Brunet, Mercè ^b   Kowalski, Richard ^c   Vinks, Alexander ^d,e   Wallemacq, Pierre ^f  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Cylex Incorporated   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT;

ALGORITHM; DRUG MONITORING; DRUG RESPONSE; GENE EXPRESSION PROFILING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NOTE; PERSONALIZED MEDICINE; PHARMACODYNAMICS; PHARMACOGENETICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DRUG MONITORING; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INDIVIDUALIZED MEDICINE; SENSITIVITY AND SPECIFICITY;

EID: 79952212963     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.159871     Document Type: Note

References (0)